Literature DB >> 30239645

Limited Coverage of Hepatitis C Virus Testing in the United States, 2013-2017.

Eshan U Patel1, Shruti H Mehta2, Denali Boon2, Thomas C Quinn3, David L Thomas4, Aaron A R Tobian1.   

Abstract

In the US household population, hepatitis C virus testing coverage marginally increased between 2013 and 2017 among persons born between 1966 and 1994 (13.2% to 16.8%) and persons born between 1945 and 1965 (12.3% to 17.3%). Testing coverage remains limited and sociodemographic disparities were observed in both populations.
© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  HCV; National Health Interview Survey; baby boomer; hepatitis; screening

Mesh：

Year:  2019        PMID： 30239645      PMCID： PMC6451991          DOI： 10.1093/cid/ciy803

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008.

Authors:  Maxine M Denniston; R Monina Klevens; Geraldine M McQuillan; Ruth B Jiles
Journal:  Hepatology       Date:  2012-04-10       Impact factor: 17.425

2.  Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2013-09-03       Impact factor: 25.391

3.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

4.  Birth Cohort Testing for Hepatitis C Virus - Indian Health Service 2012-2015.

Authors:  Brigg Reilley; Jessica Leston; Susan Hariri; Lisa Neel; Miles Rudd; Megan Galope; John Ward; Claudia Vellozzi
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-05-13       Impact factor: 17.586

5.  Hepatitis C Antibody Testing in a Commercially Insured Population, 2005-2014.

Authors:  Cheryl J Isenhour; Susan H Hariri; Craig M Hales; Claudia J Vellozzi
Journal:  Am J Prev Med       Date:  2017-02-01       Impact factor: 5.043

6.  Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic.

Authors:  Hannah Fraser; Jon Zibbell; Thomas Hoerger; Susan Hariri; Claudia Vellozzi; Natasha K Martin; Alex H Kral; Matthew Hickman; John W Ward; Peter Vickerman
Journal:  Addiction       Date:  2017-09-20       Impact factor: 6.526

7.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-10-16

8.  National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States.

Authors:  James W Galbraith; John P Donnelly; Ricardo A Franco; Edgar T Overton; Joel B Rodgers; Henry E Wang
Journal:  Clin Infect Dis       Date:  2014-06-09       Impact factor: 9.079

9.  Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States.

Authors:  Joshua A Barocas; Abriana Tasillo; Golnaz Eftekhari Yazdi; Jianing Wang; Claudia Vellozzi; Susan Hariri; Cheryl Isenhour; Liisa Randall; John W Ward; Jonathan Mermin; Joshua A Salomon; Benjamin P Linas
Journal:  Clin Infect Dis       Date:  2018-08-01       Impact factor: 20.999

10.  Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations.

Authors:  Joshua A Barocas; Jianing Wang; Laura F White; Abriana Tasillo; Joshua A Salomon; Kenneth A Freedberg; Benjamin P Linas
Journal:  Health Aff (Millwood)       Date:  2017-12       Impact factor: 9.048
View more
  8 in total

1.  Reply to MacDonald et al.

Authors:  Eshan U Patel; Shruti H Mehta; Denali Boon; Thomas C Quinn; David L Thomas; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

Review 2.  Population-based screening of hepatitis C virus in the United States.

Authors:  John Bian; Andrew D Schreiner
Journal:  Curr Opin Gastroenterol       Date:  2019-05       Impact factor: 3.287

3.  Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical Center.

Authors:  H Jensie Burton; Aastha Khatiwada; Dongjun Chung; Eric G Meissner
Journal:  South Med J       Date:  2022-06       Impact factor: 0.810

4.  Testing for Hepatitis C Virus Infection Among Adults Aged ≥18 in the United States, 2013-2017.

Authors:  Hope King; J E Soh; William W Thompson; Jessica Rogers Brown; Karina Rapposelli; Claudia Vellozzi
Journal:  Public Health Rep       Date:  2021-10-04       Impact factor: 3.117

5.  Impact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centre.

Authors:  Timothy J Whitman; Cindy D Noyes; Andrew J Hale; Devika Singh; Stephen G DeVoe; Allen B Repp; Kristen K Pierce; Louis B Polish; Beth D Kirkpatrick; Jean Dejace; Lindsay M Smith; Tim Lahey; Christopher D Huston; Laura J Catoe; Prateek Ghatage; Sean Bullis; W Kemper Alston
Journal:  BMJ Open Qual       Date:  2021-02

6.  Do patients at high risk for Hepatitis C receive recommended testing? A retrospective cohort study of statewide Medicaid claims linked with OneFlorida clinical data.

Authors:  Rahma S Mkuu; Elizabeth A Shenkman; Keith E Muller; Tianyao Huo; Ramzi G Salloum; Roniel Cabrera; Ali Zarrinpar; Emmanuel Thomas; Sarah M Szurek; David R Nelson
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

7.  The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population.

Authors:  Nicole D Ferrante; Craig W Newcomb; Kimberly A Forde; Charles E Leonard; Jessie Torgersen; Benjamin P Linas; Sarah E Rowan; David L Wyles; Jay Kostman; Stacey B Trooskin; Vincent Lo Re
Journal:  Open Forum Infect Dis       Date:  2022-09-02       Impact factor: 4.423

8.  A Population-Based Intervention to Improve Care Cascades of Patients With Hepatitis C Virus Infection.

Authors:  John Scott; Meaghan Fagalde; Atar Baer; Sara Glick; Elizabeth Barash; Hilary Armstrong; Kris V Kowdley; Matthew R Golden; Alexander J Millman; Noele P Nelson; Lauren Canary; Matthew Messerschmidt; Pallavi Patel; Michael Ninburg; Jeff Duchin
Journal:  Hepatol Commun       Date:  2020-11-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.